lomerizine has been researched along with n-methylaspartate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hara, H; Shimazawa, M; Sukamoto, T; Yokota, K | 1 |
| Chavko, M; Danielisová, V | 1 |
| Araie, M; Hara, H; Ito, Y; Nakamura, S; Shimazawa, M; Tanaka, H; Tsuruma, K | 1 |
| Hayashi, T; Murata, T; Nakamura-Yanagidaira, T; Sano, K; Takahashi, Y | 1 |
4 other study(ies) available for lomerizine and n-methylaspartate
| Article | Year |
|---|---|
Effect of KB-2796, a new diphenylpiperazine Ca2+ antagonist, on glutamate-induced neurotoxicity in rat hippocampal primary cell cultures.
Topics: Animals; Calcium Channel Agonists; Calcium Channel Blockers; Cell Survival; Cells, Cultured; Chelating Agents; Female; Glutamates; Glutamic Acid; Hippocampus; N-Methylaspartate; Nervous System Diseases; Piperazines; Pregnancy; Rats; Rats, Wistar | 1993 |
Comparative effects of the N-methyl-D-aspartate antagonist MK-801 and the calcium channel blocker KB-2796 on neurologic and metabolic recovery after spinal cord ischemia.
Topics: Adenosine Triphosphate; Animals; Calcium Channel Blockers; Dizocilpine Maleate; Energy Metabolism; Excitatory Amino Acid Antagonists; Hindlimb; Ischemia; Lactic Acid; N-Methylaspartate; Piperazines; Rabbits; Reperfusion; Spinal Cord | 1998 |
Lomerizine, a Ca2+ channel blocker, protects against neuronal degeneration within the visual center of the brain after retinal damage in mice.
Topics: Animals; Calcium Channel Blockers; Disease Models, Animal; Geniculate Bodies; Male; Mice; Mice, Inbred C57BL; N-Methylaspartate; Nerve Degeneration; Phosphopyruvate Hydratase; Piperazines; Proto-Oncogene Proteins c-fos; Retinal Diseases; Retinal Ganglion Cells; Statistics, Nonparametric; Superior Colliculi; Time Factors; Visual Pathways | 2010 |
Development of spontaneous neuropathy in NF-κBp50-deficient mice by calcineurin-signal involving impaired NF-κB activation.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Calcineurin; Genes, Reporter; Humans; Intravitreal Injections; Luciferases; Memantine; Mice; Mice, Inbred C57BL; Mice, Knockout; N-Methylaspartate; Neuroprotective Agents; NF-kappa B p50 Subunit; Optic Nerve; Optic Nerve Diseases; Piperazines; Retinal Ganglion Cells; Signal Transduction; Tacrolimus | 2011 |